close
MENU
Business
11 mins to read

Pictor’s long, slow road to commercialisation speeds up

Animal health could be a bigger money-spinner than human.

Pictor developed patented immune-diagnostic technology platform that allowed simple and reliable blood testing.

Sixteen years ago husband and wife team Anand and Sarita Kumble set up Auckland-based biotech company Pictor to make diagnostic testing for infectious diseases affordable for emerging countries.

The biochemists developed a patented immune-diagnostic technology platform that allowed simple and

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Wed, 13 Jul 2022
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Pictor’s long, slow road to commercialisation speeds up
Business,
94793
true